{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:45:08Z","timestamp":1746333908932},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T00:00:00Z","timestamp":1280448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10549-010-1065-y","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T04:59:38Z","timestamp":1280379578000},"page":"85-95","source":"Crossref","is-referenced-by-count":13,"title":["Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1\/2 breast cancer patients"],"prefix":"10.1007","volume":"128","author":[{"given":"Laura C.","family":"Hautala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Koistinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuomas","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4ivi","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Blomqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Koistinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,30]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/er.2001-0026","volume":"23","author":"M Sepp\u00e4l\u00e4","year":"2002","unstructured":"Sepp\u00e4l\u00e4 M, Taylor RN, Koistinen H et al (2002) Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401\u2013430","journal-title":"Endocr Rev"},{"key":"1065_CR2","doi-asserted-by":"crossref","first-page":"32159","DOI":"10.1074\/jbc.271.50.32159","volume":"271","author":"HR Morris","year":"1996","unstructured":"Morris HR, Dell A, Easton RL et al (1996) Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem 271:32159\u201332167","journal-title":"J Biol Chem"},{"key":"1065_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jri.2009.04.012","volume":"83","author":"WS Yeung","year":"2009","unstructured":"Yeung WS, Lee KF, Koistinen R et al (2009) Effects of glycodelins on functional competence of spermatozoa. J Reprod Immunol 83:26\u201330","journal-title":"J Reprod Immunol"},{"key":"1065_CR4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jri.2009.06.261","volume":"83","author":"A Alok","year":"2009","unstructured":"Alok A, Karande AA (2009) The role of glycodelin as an immune-modulating agent at the feto-maternal interface. J Reprod Immunol 83:124\u2013127","journal-title":"J Reprod Immunol"},{"key":"1065_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1530\/EJE-08-0756","volume":"160","author":"M Sepp\u00e4l\u00e4","year":"2009","unstructured":"Sepp\u00e4l\u00e4 M, Koistinen H, Koistinen R et al (2009) Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol 160:121\u2013133","journal-title":"Eur J Endocrinol"},{"key":"1065_CR6","first-page":"565","volume":"77","author":"M Kam\u00e4r\u00e4inen","year":"1997","unstructured":"Kam\u00e4r\u00e4inen M, Sepp\u00e4l\u00e4 M, Virtanen I et al (1997) Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 77:565\u2013573","journal-title":"Lab Invest"},{"key":"1065_CR7","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/ijc.23773","volume":"123","author":"LC Hautala","year":"2008","unstructured":"Hautala LC, Koistinen R, Sepp\u00e4l\u00e4 M et al (2008) Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer 123:2279\u20132284","journal-title":"Int J Cancer"},{"key":"1065_CR8","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.ajog.2005.05.073","volume":"193","author":"H Koistinen","year":"2005","unstructured":"Koistinen H, Sepp\u00e4l\u00e4 M, Nagy B et al (2005) Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells. Am J Obstet Gynecol 193:1955\u20131960","journal-title":"Am J Obstet Gynecol"},{"key":"1065_CR9","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1210\/en.2005-0359","volume":"146","author":"H Uchida","year":"2005","unstructured":"Uchida H, Maruyama T, Nagashima T et al (2005) Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 146:5365\u20135373","journal-title":"Endocrinology"},{"key":"1065_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/molehr\/gam081","volume":"14","author":"K Ohta","year":"2008","unstructured":"Ohta K, Maruyama T, Uchida H et al (2008) Glycodelin blocks progression to S phase and inhibits cell growth: a possible progesterone-induced regulator for endometrial epithelial cell growth gycodelin inhibits G1\/S progression. Mol Hum Reprod 14:17\u201322","journal-title":"Mol Hum Reprod"},{"key":"1065_CR11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/00365510903056023","volume":"69","author":"H Koistinen","year":"2009","unstructured":"Koistinen H, Hautala LC, Sepp\u00e4l\u00e4 M et al (2009) The role of glycodelin in cell differentiation and tumor growth. Scand J Clin Lab Invest 69:452\u2013459","journal-title":"Scand J Clin Lab Invest"},{"key":"1065_CR12","first-page":"6258","volume":"63","author":"E Mandelin","year":"2003","unstructured":"Mandelin E, Lassus H, Sepp\u00e4l\u00e4 M et al (2003) Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res 63:6258\u20136264","journal-title":"Cancer Res"},{"key":"1065_CR13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<738::AID-IJC7>3.0.CO;2-F","volume":"83","author":"M K\u00e4m\u00e4r\u00e4inen","year":"1999","unstructured":"K\u00e4m\u00e4r\u00e4inen M, Halttunen M, Koistinen R et al (1999) Expression of glycodelin in human breast and breast cancer. Int J Cancer 83:738\u2013742","journal-title":"Int J Cancer"},{"key":"1065_CR14","first-page":"413","volume":"13","author":"U Jeschke","year":"2005","unstructured":"Jeschke U, Mylonas I, Kunert-Keil C et al (2005) Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep 13:413\u2013419","journal-title":"Oncol Rep"},{"key":"1065_CR15","first-page":"467","volume":"24","author":"C Scholz","year":"2009","unstructured":"Scholz C, Toth B, Barthell E et al (2009) Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity. Histol Histopathol 24:467\u2013471","journal-title":"Histol Histopathol"},{"key":"1065_CR16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","volume":"92","author":"K Syrj\u00e4koski","year":"2000","unstructured":"Syrj\u00e4koski K, Vahteristo P, Eerola H et al (2000) Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92:1529\u20131531","journal-title":"J Natl Cancer Inst"},{"key":"1065_CR17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ijc.20638","volume":"113","author":"O Kilpivaara","year":"2005","unstructured":"Kilpivaara O, Bartkova J, Eerola H et al (2005) Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients. Int J Cancer 113:575\u2013580","journal-title":"Int J Cancer"},{"key":"1065_CR18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0959-8049(00)00093-9","volume":"36","author":"H Eerola","year":"2000","unstructured":"Eerola H, Blomqvist C, Pukkala E et al (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143\u20131148","journal-title":"Eur J Cancer"},{"key":"1065_CR19","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/hmg\/6.13.2309","volume":"6","author":"P Vehmanen","year":"1997","unstructured":"Vehmanen P, Friedman LS, Eerola H et al (1997) Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 6:2309\u20132315","journal-title":"Hum Mol Genet"},{"key":"1065_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1054\/bjoc.2000.1626","volume":"84","author":"P Vahteristo","year":"2001","unstructured":"Vahteristo P, Eerola H, Tamminen A et al (2001) A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer 84:704\u2013708","journal-title":"Br J Cancer"},{"key":"1065_CR21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","volume":"71","author":"P Vahteristo","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H et al (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432\u2013438","journal-title":"Am J Hum Genet"},{"key":"1065_CR22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403\u2013410","journal-title":"Histopathology"},{"key":"1065_CR23","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1158\/1078-0432.CCR-05-0173","volume":"11","author":"J Tommiska","year":"2005","unstructured":"Tommiska J, Eerola H, Heinonen M et al (2005) Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 11:5098\u20135103","journal-title":"Clin Cancer Res"},{"key":"1065_CR24","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1158\/1078-0432.CCR-07-4100","volume":"14","author":"K Aaltonen","year":"2008","unstructured":"Aaltonen K, Blomqvist C, Amini RM et al (2008) Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers. Clin Cancer Res 14:1976\u20131983","journal-title":"Clin Cancer Res"},{"key":"1065_CR25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2559.2007.02798.x","volume":"51","author":"C Ahlin","year":"2007","unstructured":"Ahlin C, Aaltonen K, Amini RM et al (2007) Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology 51:491\u2013498","journal-title":"Histopathology"},{"key":"1065_CR26","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","volume":"15","author":"T Heikkinen","year":"2009","unstructured":"Heikkinen T, K\u00e4rkk\u00e4inen H, Aaltonen K et al (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15:3214\u20133222","journal-title":"Clin Cancer Res"},{"key":"1065_CR27","doi-asserted-by":"crossref","unstructured":"Blows FM, Driver KE, Schmidt MK et al (2010) Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 7:e1000279","DOI":"10.1371\/journal.pmed.1000279"},{"key":"1065_CR28","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","volume":"23","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23:9067\u20139072","journal-title":"J Clin Oncol"},{"key":"1065_CR29","doi-asserted-by":"crossref","first-page":"R465","DOI":"10.1186\/bcr1025","volume":"7","author":"H Eerola","year":"2005","unstructured":"Eerola H, Heikkil\u00e4 P, Tamminen A et al (2005) Relationship of patients\u2019 age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 7:R465\u2013R469","journal-title":"Breast Cancer Res"},{"key":"1065_CR30","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80","journal-title":"Genome Biol"},{"key":"1065_CR31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du P, Kibbe WA, Lin SM (2008) Lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547\u20131548","journal-title":"Bioinformatics"},{"key":"1065_CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad BM, Irizarry RA, Astrand M et al (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185\u2013193","journal-title":"Bioinformatics"},{"key":"1065_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-60327-241-4_2","volume":"609","author":"T Tatusova","year":"2010","unstructured":"Tatusova T (2010) Genomic databases and resources at the national center for biotechnology information. Methods Mol Biol 609:17\u201344","journal-title":"Methods Mol Biol"},{"key":"1065_CR34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357","journal-title":"Nat Protoc"},{"key":"1065_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-008-9908-5","volume":"113","author":"K Aaltonen","year":"2009","unstructured":"Aaltonen K, Amini RM, Landberg G et al (2009) Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer. Breast Cancer Res Treat 113:75\u201382","journal-title":"Breast Cancer Res Treat"},{"key":"1065_CR36","doi-asserted-by":"crossref","unstructured":"Ren S, Liu S, Howell PM Jr et al (2009) Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med. doi: 10.1111\/j.1582-4934.2009.00922.x","DOI":"10.1111\/j.1582-4934.2009.00922.x"},{"key":"1065_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000123846","volume":"75","author":"J Palacios","year":"2008","unstructured":"Palacios J, Robles-Frias MJ, Castilla MA et al (2008) The molecular pathology of hereditary breast cancer. Pathobiology 75:85\u201394","journal-title":"Pathobiology"},{"key":"1065_CR38","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/carcin\/bgn157","volume":"29","author":"L Melchor","year":"2008","unstructured":"Melchor L, Benitez J (2008) An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes. Carcinogenesis 29:1475\u20131482","journal-title":"Carcinogenesis"},{"key":"1065_CR39","doi-asserted-by":"crossref","unstructured":"Waddell N, Arnold J, Cocciardi S et al (2009) Subtypes of familial breast tumours revealed by expression and copy number profiling. Breast Cancer Res Treat. doi: 10.1007\/s10549-009-0653-1","DOI":"10.1007\/s10549-009-0653-1"},{"key":"1065_CR40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrc2840","volume":"10","author":"O Fletcher","year":"2010","unstructured":"Fletcher O, Houlston RS (2010) Architecture of inherited susceptibility to common cancer. Nat Rev Cancer 10:353\u2013361","journal-title":"Nat Rev Cancer"},{"key":"1065_CR41","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","volume":"42","author":"A Meindl","year":"2010","unstructured":"Meindl A, Hellebrand H, Wiek C et al (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42:410\u2013414","journal-title":"Nat Genet"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1065-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1065-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T19:55:45Z","timestamp":1559332545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1065-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,30]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1065-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,30]]}}}